50MEDIUM

CBL

CTRLBIONIC FPO [CBL]
Healthcare · ASX Small Cap
$0.0590 -1.7%

Updated 2026-03-02 · Scores refresh every scan

Appeared in 3 consecutive scans→ Score -3First seen: 2026-02-25

Score Breakdown

Technical41
Catalyst50
Sentiment50
Fundamental53
Momentum76
Risk Gate47

Active Signals

Bullish Signals

  • Bollinger squeeze (breakout building)
  • Sustained volume spike (3.6x median) on DOWN trend
  • OBV divergence: distribution detected
  • Volatility expanding rapidly (choppy)
  • Above 200-day MA (long-term uptrend)
  • Critical cash runway (0.6 quarters)
  • Low P/S ratio (4.0x)
  • Strong revenue growth (+36%)
  • Small-cap ($20-100M)
  • CANSLIM S: Tight float (23%)
  • CANSLIM I: Institutional ownership (18%)
  • Strong 12-1 momentum (+54%)
  • Strong revenue momentum (+36%)
  • ASX200 bullish (+1.5% 5d)
  • RBA cutting (+2pts)

Risk Signals

  • Negative 5-day momentum (-3.3%)
  • Deeply negative margins (-99%)
  • Insufficient sentiment data (defaulting to neutral)
  • Neutral/mixed sentiment

Recent Catalysts

NONE Investor call presentation
NONE Joint venture with NextLevel Assistive Technology
NONE Half Yearly Report and Accounts

Recent ASX Announcements

2026-02-25 Investor call presentation
2026-02-25 Joint venture with NextLevel Assistive Technology PRICE SENSITIVE
2026-02-25 Half Yearly Report and Accounts PRICE SENSITIVE
2026-02-25 Investor Briefing
2026-01-28 PRC-Saltillo - Distribution Agreement PRICE SENSITIVE

Key Metrics

$24.7M
Market Cap
205K
Avg Volume
3.6x
Vol Ratio
$0.03 — $0.09
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-103.7%
ROE
-99.4%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 23%
LLeader vs LaggardlaggardRS: -5
IInstitutional SponsorshippassInst: 18%
MMarket DirectionpassBullish

Sector: Healthcare

Ranked #74 of 119 · Sector avg: 51

View all Healthcare signals →
Related Tickers
AVE 66CUV 64NEU 60HLS 59IMM 59

Sign up free to unlock CBL analysis

Score breakdowns, signals, catalysts, and full analysis for 2,200+ ASX small caps. All features free during early access.

No credit card required. Unsubscribe anytime.
Already have access? Log in